Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10870693
APP PUB NO 20180346556A1
SERIAL NO

15966247

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods for treating cancer comprising administering a DLL4 antagonist and one or more anti-hypertensive agents are described. Also described are pharmaceutical compositions comprising a DLL4 antagonist and one or more anti-hypertensive agents, and kits comprising the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEREO BIOPHARMA 5 INC800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Benner, Steven Eugene Seattle, US 10 100
Stagg, Robert Joseph Moraga, US 13 117

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 22, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 22, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00